Results
|
7821.
|
|
|
7822.
|
|
|
7823.
|
|
|
7824.
|
|
|
7825.
|
|
|
7826.
|
|
|
7827.
|
|
|
7828.
|
RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model. [electronic resource] by
- Ignatoski, K M Woods
- Escara-Wilke, J F
- Dai, J-L
- Lui, A
- Dougall, W
- Daignault, S
- Yao, Z
- Zhang, J
- Day, M L
- Sargent, E E
- Keller, E T
Producer: 20080620
In:
The Prostate vol. 68
Availability: No items available.
|
|
7829.
|
|
|
7830.
|
|
|
7831.
|
|
|
7832.
|
|
|
7833.
|
|
|
7834.
|
|
|
7835.
|
Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. [electronic resource] by
- Kong, Sun-Young
- Lim, Hyeong-Seok
- Nam, Byung-Ho
- Kook, Myeong-Cherl
- Kim, Young-Woo
- Ryu, Keun Won
- Lee, Jun Ho
- Choi, Il Ju
- Lee, Jin Soo
- Park, Young-Iee
- Kim, Noe Kyeong
- Park, Sook Ryun
Producer: 20100325
In:
Pharmacogenomics vol. 10
Availability: No items available.
|
|
7836.
|
|
|
7837.
|
|
|
7838.
|
|
|
7839.
|
|
|
7840.
|
|